Antisense oligonucleotides (ASO) for gene expression increase
Search documents
Camp4 Therapeutics (NasdaqGM:CAMP) 2026 Conference Transcript
2026-03-09 13:42
Camp4 Therapeutics (NasdaqGM:CAMP) 2026 Conference March 09, 2026 08:40 AM ET Company ParticipantsJosh Mandel-Brehm - President and CEOLili Nsongo - VP of Biotechnology Equity ResearchConference Call ParticipantsNone - AnalystLili NsongoWelcome everyone to the Global Healthcare Conference of Leerink Partners for 2026. I'm Lili Nsongo, and I'm joined today by Josh Mendel-Brehm, the CEO of CAMP4. Josh, welcome.Josh Mandel-BrehmGreat. Thank you for having us here.Lili NsongoWell, thanks for coming. Maybe we ca ...